[Morphological changes of interventricular septum in long-term follow-up cases].

Rinsho Byori

Department of Clinical Laboratory, Teikyo University Ichihara Hospital, Ichihara 299-0111.

Published: March 2003

In patients who could be followed by echocardiography for a long period, the clinical significance of sigmoid septum and basal septal hypertrophy including long-term changes was investigated in patients with hypertension. The subjects were 66 patients (24 males and 42 females, mean age: 53 +/- 12 years old) who underwent repeated echocardiography, and the initial examination and observation after long-term follow-up (mean duration of follow-up: 10.8 +/- 1.4 years) were compared. Sigmoid septum was more advanced at the time of initial examination in the hypertensive group than in the normotensive group, but it was similarly advanced after the long-term follow-up in both groups. There was no significant difference in basal septal hypertrophy between the hypertensive and normotensive groups at the time of initial examination, but significant increases in thickening were observed in the hypertensive group after the long-term follow-up. The above findings suggested that morphological changes in the interventricular septum reflect the severity of arteriosclerosis that is expected to be more advanced in hypertensive patients than in normotensive patients.

Download full-text PDF

Source

Publication Analysis

Top Keywords

long-term follow-up
16
initial examination
12
changes interventricular
8
interventricular septum
8
sigmoid septum
8
basal septal
8
septal hypertrophy
8
+/- years
8
time initial
8
hypertensive group
8

Similar Publications

Objective: Pleural metastasis (PM) is rare in patients with differentiated thyroid cancer (DTC). Radioiodine (131I) therapy has been the main treatment for postoperative metastasis and recurrence of DTC. However, clinical data on PM from DTC are limited.

View Article and Find Full Text PDF

Patients with relapsed or refractory (R/R) diffuse large B-cell lymphoma (DLBCL) have poor outcomes. Gemcitabine + oxaliplatin (GemOx) with rituximab, a standard salvage therapy, yields complete response (CR) rates of approximately 30% and median overall survival (OS) of 10-13 months. Patients with refractory disease fare worse, with a CR rate of 7% for subsequent therapies and median OS of 6 months.

View Article and Find Full Text PDF

Aims: To investigate the distribution of left atrioventricular coupling index (LACI) among patients with heart failure and left ventricular ejection fraction (LVEF)<50% and to explore its association with the combined endpoint of all-cause death or HF hospitalization at long term follow-up.

Methods And Results: Patients with HF and LVEF<50% undergoing cardiac magnetic resonance (CMR) were evaluated. Patients with atrial fibrillation or flutter were excluded.

View Article and Find Full Text PDF

Introduction: Acute kidney injury (AKI) in the setting of COVID-19 is associated with worse clinical and renal outcomes, with limited long-term data.

Aim: To evaluate critically ill COVID-19 patients with AKI that required nephrologist consultation (NC-AKI) in a tertiary hospital.

Methods: Prospective single-center cohort of critically ill COVID-19 adult patients with NC-AKI from May 1st, 2020, to April 30th, 2021.

View Article and Find Full Text PDF

Rationale: Thrombotic microangiopathies (TMA) caused by malignant hypertension is an acute and critical disease among rare diseases. Although renal biopsy pathology is a golden indicator for diagnosing kidney disease, it cannot distinguish between primary and secondary TMA and requires a comprehensive diagnosis in conjunction with other laboratory tests and medical history.

Patient Concerns: A 33-year-old young man was hospitalized due to unexplained kidney failure.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!